CoinspeakerJohnson & Johnson Reports Better than Expected Q2 2023 Earnings, JNJ Shares Up Slightly The pharmaceutical segment reported the highest sales with about $13.71 billion, followed by MedTech with a total sales of about $7.78 billion, and the remaining accrued from the consumer health segment. Johnson & Johnson Reports Better than Expected Q2 2023 Earnings, JNJ Shares Up Slightly
Read More »Johnson & Johnson Stock Is Rising as Company Is Going to Create Coronavirus Vaccine
The stock market is famous for its volatility. While companies operating in one industry are on the rise, businesses in other spheres are suffering drops in prices. Currently, the world is obsessed with the rapidly spreading coronavirus that initially appeared in China. And obviously, it could not just pass by the pharmaceutical industry and such companies like Johnson & Johnson, producer of medical devices and pharmaceutical goods. Johnson & Johnson stock has seen growth last week....
Read More »